Drug delivery devices can be notoriously tricky to use, so our technology enables improved studies that can distinguish use error from drug performance. This allows developers to focus investment correctly, reduce costs and accelerate a new treatment’s journey to market.
As the review of ISO 11608 approaches completion, Steve Augustyn outlines the changes device manufacturers and designers should anticipate.
We look at the themes from the virtual Drug Delivery to the Lungs conference and how these mirror the work being done by CDP.
WEBINAR Improving drug delivery systems for self-administration With Bastiaan deLeeuw, Uri Baruch, Clare Beddoes and Chris Houghton 8 JUN 2020 As self-administration in the home setting grows in importance, our panel of experts discuss the continuous drive to design and improve drug delivery systems for self-administration and home-use. Enjoy the full…
The collaboration strongly supports the expansion of the Stevanato group’s portfolio of devices for patients suffering from diabetes.
Patients suffering from chronic diseases such as rheumatoid arthritis or multiple sclerosis often follow a complicated treatment regimen at home. They sometimes need to store their drugs in the fridge, warm them up to the correct temperature for injection, prepare their auto-injector for use and finally dispose of the used device safely.
Louise reflects on upcoming changes and their potential impact.
James Baker, partner at Cambridge Design Partnership, considers the future for AI in the real world with help from a sideways look at its portrayal on the big screen.
Richard proposes how innovation in blood processing could revolutionise clinical trial design.
The 2019 Parenteral Drug Association (PDA) Europe event was held recently in the beautiful Swedish city of Gothenburg, hosting over 950 attendees, including over 130 exhibiting companies – of which CDP was one. It’s always a great opportunity to catch up with industry colleagues, meet new ones and to hear…
Writing an expert view for ONdrugDelivery Magazine, Tom Lawrie-Fussey, Healthcare Digital Strategist, and Lucy Sheldon, Human Centered Design Consultant, both of Cambridge Design Partnership, introduce “Wizard of Oz” testing, named after the classic novel and film, whereby experimenters can field test concepts at a very early stage by giving the illusion of a…
Chris Houghton leads Brand Innovation & Packaging at Cambridge Design Partnership, he has worked on an array of successful insight, design and strategic innovation projects with top consumer goods names including Arla, Carlsberg, Coca-Cola, Diageo, Nestle, PepsiCo, Procter & Gamble and Unilever.Following his ‘Context is King’ keynote speeches at PACE in Amsterdam and AIPIA in…